Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Ashish V. Chintakuntlawar"'
Autor:
Kanishka Uttam Chandani, Siddharth Pravin Agrawal, Maharshi Raval, Sajid Siddiq, Ahmed Nadeem, Ashish V. Chintakuntlawar, Shahrukh K. Hashmi
Publikováno v:
Medicina, Vol 60, Iss 5, p 800 (2024)
Background and Objectives: Non-Hodgkin lymphoma (NHL) has the sixth-highest malignancy-related mortality in the United States (US). However, inequalities exist in access to advanced care in specific patient populations. We aim to study the racial dis
Externí odkaz:
https://doaj.org/article/350f2569409d421ab1be4f3f7cfb6b23
Autor:
Brady S. Laughlin, MD, Sasha Ebrahimi, MD, PhD, Molly M. Voss, BA, Samir H. Patel, MD, Robert L. Foote, MD, Lisa A. McGee, MD, Joaquin Garcia, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben Wittich, MD, Katharine A. Price, MD, Alessandra Schmitt, MD, Qihui Zhai, MD, Byron C. May, MD, Thomas H. Nagel, MD, Michael L. Hinni, MD, Ashish V. Chintakuntlawar, MBBS, PhD, Todd A. DeWees, PhD, Jean-Claude M. Rwigema, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101204- (2023)
Purpose: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. Methods and Materials: Eighty-nine patients with SDC were treated with curative intent from February 5
Externí odkaz:
https://doaj.org/article/ce5c8d672a394f028680444098efe8ba
Autor:
Roman O. Kowalchuk, MD, Kathryn M. Van Abel, MD, Adam B. Sauer, BS, Linda X. Yin, MD, Joaquin J. Garcia, MD, William S. Harmsen, MS, Eric J. Moore, MD, Daniel L. Price, MD, Ashish V. Chintakuntlawar, MD, Katharine R. Price, MD, Scott C. Lester, MD, Michelle Neben Wittich, MD, Samir H. Patel, MD, Robert L. Foote, MD, Daniel M. Ma, MD, Alex A. Nagelschneider, MD, David M. Routman, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100926- (2022)
Purpose: Human papillomavirus–associated oropharyngeal squamous cell carcinoma (HPV[+]OPSCC) requires further study to optimize the existing clinical staging system and guide treatment selection. We hypothesize that incorporation of the number of r
Externí odkaz:
https://doaj.org/article/a940f1c8ede3433dbf3bc725aa815a6b
Autor:
Paul V. Viscuse, Katharine A. Price, Joaquin J. Garcia, David J. Schembri-Wismayer, Ashish V. Chintakuntlawar
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Objectives: There is a lack of effective therapy for recurrent or metastatic salivary gland carcinoma. Androgen deprivation therapy has demonstrated efficacy in cases of salivary duct carcinoma (SDC) and high-grade adenocarcinoma not otherwise specif
Externí odkaz:
https://doaj.org/article/822b29b44d9d4269a3bec2415cb48fe7
Autor:
Laurent Humeau, David Weiner, Robert H Vonderheide, Matthew P Morrow, Trevor McMullan, Anthony F Shields, Ashish V Chintakuntlawar, Kimberly A Kraynyak, Autumn J McRee, Jennifer M Johnson, Weijing Sun, Jan Pawlicki, Albert J Sylvester, Robert Samuels, Joseph J Kim, Jean D Boyer, Jeffrey M Skolnik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Human telomerase reverse transcriptase (hTERT) is frequently classified as a ‘universal’ tumor associated antigen due to its expression in a vast number of cancers. We evaluated plasmid DNA-encoded hTERT as an immunotherapy across nine
Externí odkaz:
https://doaj.org/article/a019d7273be04e4cbb43557f12c156de
Autor:
Mabel Ryder, Mouhammed Amir Habra, Matthew Campbell, Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D Eaton, Jeffrey Thomas Yorio, Davey B Daniel, Keith C Bible, Ashish V Chintakuntlawar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background There is no effective systemic therapy for metastatic adrenal cortical carcinoma (ACC) after failure of platinum-based chemotherapy. The efficacies of single-agent oral multikinase inhibitors (MKIs) or salvage immune checkpoint inhibitors
Externí odkaz:
https://doaj.org/article/4a195cbe866047b8a6068d0918bac22f
Autor:
Katharine, Price, Kathryn M, Van Abel, Eric J, Moore, Samir H, Patel, Michael L, Hinni, Ashish V, Chintakuntlawar, Darlene, Graner, Michelle, Neben-Wittich, Yolanda I, Garces, Daniel L, Price, Jeffrey R, Janus, Nathan R, Foster, Brenda F, Ginos, Robert L, Foote, Daniel, Ma
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:256-265
Patients with human papillomavirus oropharyngeal cancer are highly curable but risk significant long-term toxic effects with standard therapy. This study investigated a de-escalation strategy of decreased adjuvant radiation therapy and chemotherapy a
Autor:
David M. Routman, Sunil Kumar, Bisham S. Chera, Krishan R. Jethwa, Kathryn M. Van Abel, Kelsey Frechette, Todd DeWees, Michael Golafshar, Joaquin J. Garcia, Daniel L. Price, Jan L. Kasperbauer, Samil H. Patel, Michelle A. Neben-Wittich, Nadia L. Laack, Ashish V. Chintakuntlawar, Katharine A. Price, Minetta C. Liu, Robert L. Foote, Eric J. Moore, Gaorav P. Gupta, Daniel J. Ma
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:530-538
The purpose of our study is to determine the rate of detectability of ctHPVDNA after surgery but before adjuvant therapy in patients with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (HPV[+]OPSCC) and to investigate whe
Autor:
Crystal S. Denlinger, Rakesh Kumar, Shahram Rahimian, Nicholas Durham, Jennifer Cann, Nathan Standifer, Ignacio González-García, Nairouz Elgeioushi, Philip R. Mallinder, Michael Gordon, Helen J. Ross, Naiyer A. Rizvi, Ashish V. Chintakuntlawar, Aung Naing, Raid Aljumaily, Jeffrey R. Infante, Ani S. Balmanoukian
Visits after Day 57 were excluded for visual purposes. The excluded visits were: Days 71, 85, 99, 127, 155, 183, 211, 239, 267, 295, 323 and 351.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c57f05b7487dca90ac1ad84657cf781
https://doi.org/10.1158/1078-0432.22476206
https://doi.org/10.1158/1078-0432.22476206
Autor:
Crystal S. Denlinger, Rakesh Kumar, Shahram Rahimian, Nicholas Durham, Jennifer Cann, Nathan Standifer, Ignacio González-García, Nairouz Elgeioushi, Philip R. Mallinder, Michael Gordon, Helen J. Ross, Naiyer A. Rizvi, Ashish V. Chintakuntlawar, Aung Naing, Raid Aljumaily, Jeffrey R. Infante, Ani S. Balmanoukian
Purpose:The safety and preliminary efficacy of MEDI1873, an agonistic IgG1 fusion protein targeting glucocorticoid-induced TNF receptor–related protein (GITR), were evaluated in an open-label, first-in-human, phase I, dose escalation study in previ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0605789afd98cafb5792cdb8e4a7e2c5
https://doi.org/10.1158/1078-0432.c.6529325.v1
https://doi.org/10.1158/1078-0432.c.6529325.v1